RESPONSE OF PSORIASIS TO BETAMETHASONE VALERATE AND CLOBETASOL PROPIONATE - 6-MONTH CONTROLLED-STUDY

被引:16
作者
CORBETT, MF [1 ]
机构
[1] NORTHWICK PK HOSP,DEPT DERMATOL,WATFORD RD,HARROW,ENGLAND
关键词
D O I
10.1111/j.1365-2133.1976.tb02275.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:89 / 93
页数:5
相关论文
共 7 条
[1]   COMPLICATIONS OF TOPICAL CORTICOSTEROID-THERAPY IN PATIENTS WITH LIVER-DISEASE [J].
BURTON, JL ;
CUNLIFFE, WJ ;
HOLTI, G ;
WRIGHT, V .
BRITISH JOURNAL OF DERMATOLOGY, 1974, 91 :22-23
[2]  
FEIWEL M, 1968, 13 P INT DERM C, V1, P202
[3]  
JAMES VHT, 1967, LANCET, V2, P1059
[4]   CLINICAL EVALUATION OF A NEW TOPICAL CORTICOSTEROID, CLOBETASOL PROPIONATE - INTERNATIONAL CONTROLLED TRAIL [J].
SPARKES, CG ;
WILSON, L .
BRITISH JOURNAL OF DERMATOLOGY, 1974, 90 (02) :197-203
[5]   CUSHINGS-SYNDROME AND PITUITARY-ADRENAL SUPPRESSION DUE TO CLOBETASOL PROPIONATE [J].
STAUGHTON, RCD ;
AUGUST, PJ .
BRITISH MEDICAL JOURNAL, 1975, 2 (5968) :419-421
[6]   EFFECT ON PLASMA CORTICOSTEROID LEVELS OF SHORT-TERM TOPICAL APPLICATION OF CLOBETASOL PROPIONATE [J].
WALKER, SR ;
WILSON, L ;
FRY, L ;
JAMES, VHT .
BRITISH JOURNAL OF DERMATOLOGY, 1974, 91 (03) :339-343
[7]  
WILLIAMS DI, 1964, LANCET, V1, P1177